Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats
Article
Article Title | Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats |
---|---|
ERA Journal ID | 39745 |
Article Category | Article |
Authors | Nadhanan, Rethi Raghu (Author), Skinner, Jayne (Author), Chung, Rosa (Author), Su, Yu-Wen (Author), Howe, Peter R. (Author) and Xian, Cory J. (Author) |
Journal Title | PLoS One |
Journal Citation | 8 (8) |
Number of Pages | 12 |
Year | 2013 |
Publisher | Public Library of Science (PLoS) |
Place of Publication | United States |
ISSN | 1932-6203 |
Digital Object Identifier (DOI) | https://doi.org/10.1371/journal.pone.0071592 |
Web Address (URL) | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071592 |
Abstract | Cancer chemotherapy has been shown to induce long-term skeletal side effects such as osteoporosis and fractures; however, there are no preventative treatments. This study investigated the damaging effects of anti-metabolite methotrexate (MTX) subcutaneous injections (0.75 mg/kg BW) for five days and the potential protective benefits of daily oral gavage of fish oil at 0.5 mL/100 g BW (containing 375 mg of n-3 PUFA/100 g BW), genistein (2 mg/100 g BW), or their combination in young adult rats. MTX treatment alone significantly reduced primary spongiosa height and secondary spongiosa trabecular bone volume. Bone marrow stromal cells from the treated rats showed a significant reduction in osteogenic differentiation but an increase in adipogenesis ex vivo. Consistently, stromal cells had significantly higher mRNA levels of adipogenesis-related proliferator activator activated receptor-γ (PPAR-γ) and fatty acid binding protein (FABP4). MTX significantly increased the numbers of bone-resorbing osteoclasts and marrow osteoclast precursor cell pool while significantly enhancing the mRNA expression of receptor activator for nuclear factor kappa B ligand (RANKL), the RANKL/osteoprotegerin (OPG) ratio, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in the bone. Supplementary treatment with fish oil and/or genistein significantly preserved trabecular bone volume and osteogenesis but suppressed MTX-induced adipogenesis and increases in osteoclast numbers and pro-osteoclastogenic cytokine expression. Thus, Fish oil and/or genistein supplementation during MTX treatment enabled not only preservation of osteogenic differentiation, osteoblast number and bone volume, but also prevention of MTX treatment-induced increases in bone marrow adiposity, osteoclastogenic cytokine expression and osteoclast formation, and thus bone loss. © 2013 Raghu Nadhanan et al. |
Keywords | clinical and experimental biochemistry; orthopedic surgery; Drug Literature Index; toxicology; |
ANZSRC Field of Research 2020 | 321105. Chemotherapy |
Public Notes | File reproduced in accordance with the copyright policy of the publisher/author. |
Byline Affiliations | University of South Australia |
University of Newcastle | |
Institution of Origin | University of Southern Queensland |
https://research.usq.edu.au/item/q40zv/supplementation-with-fish-oil-and-genistein-individually-or-in-combination-protects-bone-against-the-adverse-effects-of-methotrexate-chemotherapy-in-rats
Download files
Published Version
http___journals.plos.org_plosone_article_file_id=10.1371_journal.pone.pdf | ||
File access level: Anyone |
1286
total views103
total downloads0
views this month0
downloads this month